Note: Ingredients listed on restricted chemical lists
EC/CAS
220-120-9/2634-33-5
Name of the chemical
1,2-Benzisothiazol-3(2H)-one
Concentration
>=0.0025-< >=0.05%
EC/CAS
247-500-7/55965-84-9
Name of the chemical
Mixture of 5-chloro-2-methyl-2H- isothiazol-3-one (EINECS 247-500-7) and 2-methyl-2H-isothiazol-3-one (EINECS 220-239-6)
Concentration
>=0.0002-< >=0.6% 0.06-<0.6% 0.06-<0.6% >=0.0015% >=0.6%
General Information
Version
1.5
Revision date
2023-08-07
Product name
MOWILITH LD 167
1.2.1 Relevant identified uses
For industrial use only
Emergency telephone
+1 703 527 3887
Icons in SDS
Company Information
company name
Celanese Sales Germany GmbH
e-mail address of the competent person responsible for the Safety Data Sheet
HazCom@celanese.com
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 Classification of the substance or mixture
Additional information
EUH210 Safety data sheet available on request. EUH208
Contains
1,2-benzisothiazol-3(2H)-one, mixture of 5-chloro-2-methyl-4- isothiazolin-3-one [EC no. 247-500-7] and 2-methyl-2H-isothiazol-3-one [EC no. 220-239-6] (3:1). May produce an allergic reaction.
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumula- tive and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regu- lation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
2.1 Classification of the substance or mixture
Classification (REGULATION (EC) No 1272/2008) Not a hazardous substance or mixture.
